NCT02354573View on ClinicalTrials.gov

The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Heart Failure
Interventions
DRUG

Ivabradine

All subjects will receive Ivabradine 7.5mg twice daily for 2 weeks in a double-blind randomized crossover design.

Trial Locations (1)

OX3 9DU

Univesrtity of Oxford, John Radcliffe Hospital, Oxford

All Listed Sponsors
collaborator

University of Aberdeen

OTHER

lead

University of Oxford

OTHER

NCT02354573 - The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF) | Biotech Hunter | Biotech Hunter